217 related articles for article (PubMed ID: 20486899)
1. Therapeutic uses of drug-carrier systems for imidazole-containing dipeptide compounds that act as pharmacological chaperones and have significant impact on the treatment of chronic diseases associated with increased oxidative stress and the formation of advanced glycation end products.
Babizhayev MA; Yegorov YE
Crit Rev Ther Drug Carrier Syst; 2010; 27(2):85-154. PubMed ID: 20486899
[TBL] [Abstract][Full Text] [Related]
2. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.
Babizhayev MA; Kasus-Jacobi A
Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional properties, chaperone activity and posttranslational modifications of alpha-crystallin and its related subunits in the crystalline lens: N-acetylcarnosine, carnosine and carcinine act as alpha- crystallin/small heat shock protein enhancers in prevention and dissolution of cataract in ocular drug delivery formulations of novel therapeutic agents.
Babizhayev MA
Recent Pat Drug Deliv Formul; 2012 Aug; 6(2):107-48. PubMed ID: 22436026
[TBL] [Abstract][Full Text] [Related]
4. Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: pharmacokinetic assay of Can-C N-acetylcarnosine prodrug lubricant eye drops for cataract prevention.
Babizhayev MA
Drugs R D; 2005; 6(6):345-69. PubMed ID: 16274259
[TBL] [Abstract][Full Text] [Related]
5. Designation of imidazole-containing dipeptides as pharmacological chaperones.
Babizhayev MA
Hum Exp Toxicol; 2011 Jul; 30(7):736-61. PubMed ID: 20656726
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of intraocular absorption and drug metabolism of N-acetylcarnosine lubricant eye drops: drug interaction with sight threatening lipid peroxides in the treatment for age-related eye diseases.
Babizhayev MA
Drug Metabol Drug Interact; 2009; 24(2-4):275-323. PubMed ID: 20408504
[TBL] [Abstract][Full Text] [Related]
7. Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and skin aging.
Babizhayev MA; Deyev AI; Savel'yeva EL; Lankin VZ; Yegorov YE
J Dermatolog Treat; 2012 Oct; 23(5):345-84. PubMed ID: 21756141
[TBL] [Abstract][Full Text] [Related]
8. Telomere Attrition in Human Lens Epithelial Cells Associated with Oxidative Stress Provide a New Therapeutic Target for the Treatment, Dissolving and Prevention of Cataract with N-Acetylcarnosine Lubricant Eye Drops. Kinetic, Pharmacological and Activity-Dependent Separation of Therapeutic Targeting: Transcorneal Penetration and Delivery of L-Carnosine in the Aqueous Humor and Hormone-Like Hypothalamic Antiaging Effects of the Instilled Ophthalmic Drug Through a Safe Eye Medication Technique.
Babizhayev MA; Yegorov YE
Recent Pat Drug Deliv Formul; 2016; 10(2):82-129. PubMed ID: 26084629
[TBL] [Abstract][Full Text] [Related]
9. Biologic activities of molecular chaperones and pharmacologic chaperone imidazole-containing dipeptide-based compounds: natural skin care help and the ultimate challenge: implication for adaptive responses in the skin.
Babizhayev MA; Nikolayev GM; Nikolayeva JG; Yegorov YE
Am J Ther; 2012 Mar; 19(2):e69-89. PubMed ID: 20861720
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of oxidative stress and cataract. Novel drug delivery therapeutic strategies targeting telomere reduction and the expression of telomerase activity in the lens epithelial cells with N-acetylcarnosine lubricant eye drops: anti-cataract which helps to prevent and treat cataracts in the eyes of dogs and other animals.
Babizhayev MA; Yegorov YE
Curr Drug Deliv; 2014; 11(1):24-61. PubMed ID: 24783234
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50,500 patients.
Babizhayev MA; Micans P; Guiotto A; Kasus-Jacobi A
Am J Ther; 2009; 16(6):517-33. PubMed ID: 19487926
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria induce oxidative stress, generation of reactive oxygen species and redox state unbalance of the eye lens leading to human cataract formation: disruption of redox lens organization by phospholipid hydroperoxides as a common basis for cataract disease.
Babizhayev MA
Cell Biochem Funct; 2011 Apr; 29(3):183-206. PubMed ID: 21381059
[TBL] [Abstract][Full Text] [Related]
13. Biological activities of the natural imidazole-containing peptidomimetics n-acetylcarnosine, carcinine and L-carnosine in ophthalmic and skin care products.
Babizhayev MA
Life Sci; 2006 Apr; 78(20):2343-57. PubMed ID: 16388826
[TBL] [Abstract][Full Text] [Related]
14. Bioactivation antioxidant and transglycating properties of N-acetylcarnosine autoinduction prodrug of a dipeptide L-carnosine in mucoadhesive drug delivery eye-drop formulation: powerful eye health application technique and therapeutic platform.
Babizhayev MA
Drug Test Anal; 2012 Jun; 4(6):468-85. PubMed ID: 21416634
[TBL] [Abstract][Full Text] [Related]
15. The natural histidine-containing dipeptide Nalpha-acetylcarnosine as an antioxidant for ophthalmic use.
Babizhayev MA; Yermakova VN; Semiletov YA; Deyev AI
Biochemistry (Mosc); 2000 May; 65(5):588-98. PubMed ID: 10851037
[TBL] [Abstract][Full Text] [Related]
16. N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population.
Babizhayev MA; Burke L; Micans P; Richer SP
Clin Interv Aging; 2009; 4():31-50. PubMed ID: 19503764
[TBL] [Abstract][Full Text] [Related]
17. N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications.
Babizhayev MA; Guiotto A; Kasus-Jacobi A
J Drug Target; 2009 Jan; 17(1):36-63. PubMed ID: 19037813
[TBL] [Abstract][Full Text] [Related]
18. New concept in nutrition for the maintenance of the aging eye redox regulation and therapeutic treatment of cataract disease; synergism of natural antioxidant imidazole-containing amino acid-based compounds, chaperone, and glutathione boosting agents: a systemic perspective on aging and longevity emerged from studies in humans.
Babizhayev MA
Am J Ther; 2010; 17(4):373-89. PubMed ID: 20463577
[TBL] [Abstract][Full Text] [Related]
19. An "enigmatic" L-carnosine (β-alanyl-L-histidine)? Cell proliferative activity as a fundamental property of a natural dipeptide inherent to traditional antioxidant, anti-aging biological activities: balancing and a hormonally correct agent, novel patented oral therapy dosage formulation for mobility, skeletal muscle power and functional performance, hypothalamic-pituitary- brain relationship in health, aging and stress studies.
Babizhayev MA; Yegorov YE
Recent Pat Drug Deliv Formul; 2015; 9(1):1-64. PubMed ID: 25524476
[TBL] [Abstract][Full Text] [Related]
20. Advanced drug delivery of N-acetylcarnosine (N-acetyl-beta-alanyl-L-histidine), carcinine (beta-alanylhistamine) and L-carnosine (beta-alanyl-L-histidine) in targeting peptide compounds as pharmacological chaperones for use in tissue engineering, human disease management and therapy: from in vitro to the clinic.
Babizhayev MA; Yegorov YE
Recent Pat Drug Deliv Formul; 2010 Nov; 4(3):198-230. PubMed ID: 20863274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
